These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 14739052)

  • 1. Predicting factors associated with costs of diabetic patients in Taiwan.
    Lin T; Chou P; Tsai ST; Lee YC; Tai TY
    Diabetes Res Clin Pract; 2004 Feb; 63(2):119-25. PubMed ID: 14739052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct costs-of-illness of patients with diabetes mellitus in Taiwan.
    Lin T; Chou P; Lai MS; Tsai ST; Tai TY
    Diabetes Res Clin Pract; 2001 Nov; 54 Suppl 1():S43-6. PubMed ID: 11580968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of postherpetic neuralgia and painful diabetic peripheral neuropathy on health care costs.
    Dworkin RH; Malone DC; Panarites CJ; Armstrong EP; Pham SV
    J Pain; 2010 Apr; 11(4):360-8. PubMed ID: 19853529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accountability, utilization and providers for diabetes management in Taiwan, 2000-2009: an analysis of the National Health Insurance database.
    Chang TJ; Jiang YD; Chang CH; Chung CH; Yu NC; Chuang LM
    J Formos Med Assoc; 2012 Nov; 111(11):605-16. PubMed ID: 23217596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comorbidities, healthcare service utilization and costs for patients identified with painful DPN in a managed-care setting.
    Ritzwoller DP; Ellis JL; Korner EJ; Hartsfield CL; Sadosky A
    Curr Med Res Opin; 2009 Jun; 25(6):1319-28. PubMed ID: 19419344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Heterogeneity of costs of diabetic patients: the Cost of Diabetes Mellitus Study].
    Köster I; Hauner H; von Ferber L
    Dtsch Med Wochenschr; 2006 Apr; 131(15):804-10. PubMed ID: 16607599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patterns of expenditures and use of services among older adults with diabetes. Implications for the transition to capitated managed care.
    Krop JS; Powe NR; Weller WE; Shaffer TJ; Saudek CD; Anderson GF
    Diabetes Care; 1998 May; 21(5):747-52. PubMed ID: 9589235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trend and factors associated with healthcare use and costs in type 2 diabetes mellitus: a decade experience of a universal health insurance program.
    Cheng JS; Tsai WC; Lin CL; Chen L; Lang HC; Hsieh HM; Shin SJ; Chen T; Huang CT; Hsu CC
    Med Care; 2015 Feb; 53(2):116-24. PubMed ID: 25517075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Economic costs of diabetes in the U.S. In 2007.
    American Diabetes Association
    Diabetes Care; 2008 Mar; 31(3):596-615. PubMed ID: 18308683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Better continuity of care reduces costs for diabetic patients.
    Chen CC; Chen SH
    Am J Manag Care; 2011 Jun; 17(6):420-7. PubMed ID: 21756012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of diabetes on economic costs in dialysis patients: experiences in Taiwan.
    Yang WC; Hwang SJ; Chiang SS; Chen HF; Tsai ST
    Diabetes Res Clin Pract; 2001 Nov; 54 Suppl 1():S47-54. PubMed ID: 11580969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of other diabetes-associated complications and comorbidities and its impact on health care charges among patients with diabetic neuropathy.
    Zhao Y; Ye W; Boye KS; Holcombe JH; Hall JA; Swindle R
    J Diabetes Complications; 2010; 24(1):9-19. PubMed ID: 18930413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of diabetes pay-for-performance incentive designs.
    Hsieh HM; Tsai SL; Shin SJ; Mau LW; Chiu HC
    Med Care; 2015 Feb; 53(2):106-15. PubMed ID: 25397966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accuracy of diabetes diagnosis in health insurance claims data in Taiwan.
    Lin CC; Lai MS; Syu CY; Chang SC; Tseng FY
    J Formos Med Assoc; 2005 Mar; 104(3):157-63. PubMed ID: 15818428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost of heart failure among hypertensive users of nonspecific NSAIDs and COX-2-specific inhibitors.
    Zhao SZ; Burke TA; Whelton A; von Allmen H; Henderson SC
    Am J Manag Care; 2002 Oct; 8(15 Suppl):S414-27. PubMed ID: 12416791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence and prevalence rates of diabetes mellitus in Taiwan: analysis of the 2000-2009 Nationwide Health Insurance database.
    Jiang YD; Chang CH; Tai TY; Chen JF; Chuang LM
    J Formos Med Assoc; 2012 Nov; 111(11):599-604. PubMed ID: 23217595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Health economic impact of heart failure: An analysis of the nationwide German database].
    Zugck C; Müller A; Helms TM; Wildau HJ; Becks T; Hacker J; Haag S; Goldhagen K; Schwab JO
    Dtsch Med Wochenschr; 2010 Apr; 135(13):633-8. PubMed ID: 20333603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in prevalence of diabetic complications and associated healthcare costs during a 10-year follow-up period among a nationwide diabetic cohort.
    Chen HL; Hsu WW; Hsiao FY
    J Diabetes Complications; 2015; 29(4):523-8. PubMed ID: 25770886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of diabetes mellitus on healthcare costs in Italy.
    Giorda CB; Manicardi V; Diago Cabezudo J
    Expert Rev Pharmacoecon Outcomes Res; 2011 Dec; 11(6):709-19. PubMed ID: 22098288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Healthcare costs associated with progressive diabetic retinopathy among National Health Insurance enrollees in Taiwan, 2000-2004.
    Woung LC; Tsai CY; Chou HK; Tsai MT; Tsai WH; Chou P; Shen ST
    BMC Health Serv Res; 2010 May; 10():136. PubMed ID: 20500894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.